NCT02376868View on ClinicalTrials.gov

Maestro Agreement and Precision Study II

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Normal Healthy Subjects With No Known Ocular DiseasesGlaucomatous EyesEyes With Retinal Diseases
Interventions
DEVICE

3D OCT-1 Maestro

OCT machines used for diagnostic purposes

DEVICE

iVue

OCT machines used for diagnostic purposes

Trial Locations (1)

91716

Western University of Health Sciences, Pomona

All Listed Sponsors
lead

Topcon Medical Systems, Inc.

INDUSTRY

NCT02376868 - Maestro Agreement and Precision Study II | Biotech Hunter | Biotech Hunter